Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders
Samuel T. Wilkinson, Gerard Sanacora
JAMA August 14, 2017 DOI: 10.1001/jama.2017.10697 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Anxiety Ketamine Esketamine |
| Keywords | Mood disorders Statement logic Intensive care medicine Medline Electroconvulsive therapy studies |
| Citations | 36 |
| Key points | A consensus statement addresses important issues related to the clinical use of ketamine for psychiatric disorders and provides suggestions for addressing remaining concerns. |
Abstract
This Viewpoint summarizes a number of important issues related to the clinical use of ketamine for the treatment of psychiatric disorders addressed in the consensus statement and provides suggestions for addressing remaining concerns.